Scientists discovered CD4+ T cells can directly attack cancer cells lacking MHC class I proteins Cancer cells reduce MHC class I to evade killer T cells but become vulnerable to CD4+ T cells Boosting CD4+ T cell activity may improve treatments for cancers resistant to current immunotherapies